98%
921
2 minutes
20
Background: Transglutaminase-2 (TG2) plays a key role in age-related vascular stiffness. This study aims to evaluate the effects of calorie restriction (CR) on TG2 mRNA and protein levels and identify differentially expressed microRNAs (miRNA) predicted to target TG2.
Methods And Results: Female mice were assigned to ad libitum (AL), chronic CR (CCR), and intermittent CR (ICR) groups for 80 weeks. Expression levels of miRNAs predicted to target TG2 (miR-423-5p, miR-700-5p, miR-484, miR-7048-5p, and miR-7053-5p) were identified in blood and aorta samples. TG2 mRNA expression levels in the aorta were analyzed. A similar trend was observed between blood and aorta samples for miR-423-5p, miR-484, and miR-700-5p. TG2 mRNA expression was significantly lower in the ICR-R group compared to the AL group. TG2 protein levels in aorta were lower in the CCR group than that of in the AL group in old age. Endothelial nitric oxide synthase (eNOS) protein levels were also determined owing to their role in NO-dependent TG2 regulation and were lowest in the CCR group, with an overall decline in aging mice.
Conclusions: The CR intervention reveals protective potential against vascular stiffness, as TG2 levels were lower in the aorta of aging CR mice. These findings provide translational insights into the epigenetic regulation of TG2 by CR in vascular aging.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s11033-025-10892-7 | DOI Listing |
Mol Biol Rep
August 2025
Department of Biophysics, School of Medicine, Yeditepe University, Istanbul, Turkey.
Background: Transglutaminase-2 (TG2) plays a key role in age-related vascular stiffness. This study aims to evaluate the effects of calorie restriction (CR) on TG2 mRNA and protein levels and identify differentially expressed microRNAs (miRNA) predicted to target TG2.
Methods And Results: Female mice were assigned to ad libitum (AL), chronic CR (CCR), and intermittent CR (ICR) groups for 80 weeks.
AIMS Neurosci
June 2025
First Division of Neurology and Neurophysiopathology, AOU "Luigi Vanvitelli", Naples, Italy.
The calcium-dependent enzyme Transglutaminase 2 (TG2) (E.C. 2.
View Article and Find Full Text PDFNat Struct Mol Biol
July 2025
Joseph Henry Laboratories of Physics & Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA.
Transcription commonly occurs in bursts, with alternating productive (ON) and quiescent (OFF) periods determining mRNA production rates. However, how bursting dynamics regulate transcription is not well understood. Here, we conduct real-time measurements of endogenous transcriptional bursting with single-mRNA sensitivity.
View Article and Find Full Text PDFInt J Mol Sci
June 2025
Department of Biomedicine, Health, Aarhus University, 8000 Aarhus C, Denmark.
The enzyme transglutaminase 2 (TG2) has an open conformation with transamidase activity which crosslinks matrix proteins contributing to fibrosis development. LDN-27219 promotes the closed conformation of TG2, which can enhance vasodilation, but its effects in renal tissue are unknown. We investigated whether LDN-27219 treatment affects albuminuria and markers of renal fibrosis as well as ex vivo vasodilatation.
View Article and Find Full Text PDFLife Sci
April 2025
Department of Biomedicine, Health, Aarhus University, Denmark; Department of Renal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Aims: The open conformation of the enzyme transglutaminase 2 (TG2) contributes to kidney fibrosis through transamidase activity by cross-linking extracellular matrix fibres and releasing transforming growth factor β1 (TGFβ1), a key driver of fibrogenesis. We investigated the antifibrotic potential of TG2 inhibition downstream of TGFβ1 using two TG2 inhibitors, LDN27219 and Z-DON, which modulate TG2 into the closed and open state, respectively.
Materials And Methods: The TG2 inhibitors were studied in human precision-cut kidney slices (PCKS) and in cell cultures of primary renal cell types: endothelial and epithelial cells, and fibroblasts.